FDA Investigator: Jonathan W. Chapman

- Jonathan W. Chapman first started conducting FDA inspections in 2013, with the last inspection in 2021. Over that time, Jonathan W. Chapman has conducted 66 inspections at 58 companies across 60 sites.

Documents

FDA 483 Wuxi Biologics, Wuxi | April 2021

Available - $199
Jonathan W. Chapman
Human Drug Form 483

FDA 483 Viwit Pharmaceutical, Tengzhou | October 2019

Available - $199
Jonathan W. Chapman
Human Drug Form 483

FDA 483 Xiamen Pharmaceutical, Xiamen | November 2018

Available - $199
Jonathan W. Chapman
Human Drug Form 483

FDA 483 Zhejiang Poly Pharm. Co., Ltd, Hangzhou | 2020

Out-of-stock
Jonathan W. Chapman
Human Drug Form 483

FDA 483 Shandong Anhong Pharmaceutical Co., Ltd., Dezhou | 2020

Out-of-stock
Jonathan W. Chapman
Human Drug Form 483

FDA 483 The United Laboratories (Inner Mongolia) Co. Ltd., Bayan Nur | 2020

Out-of-stock
Jonathan W. Chapman
Human Drug Form 483

FDA 483 Zhejiang Huahai Pharmaceutical Co., Ltd., Taizhou | 2019

Out-of-stock
Jonathan W. Chapman
Human Drug Form 483

FDA 483 Zhejiang Huahai Pharmaceutical Co., Ltd., Taizhou | 2019

Out-of-stock
Jonathan W. Chapman
Human Drug Form 483

FDA 483 Yino Pharma Limited, Chongqing | 2019

Out-of-stock
Jonathan W. Chapman
Human Drug Form 483

FDA 483 Aurisco Pharmaceutical Co., Ltd, Tiantai | 2019

Out-of-stock
Jonathan W. Chapman
Human Drug Form 483

FDA 483 Shanghai Institute of Measurement and Testing Technology, Shanghai | 2018

Out-of-stock
Jonathan W. Chapman
Human Drug Form 483

FDA 483 Hangzhou Zhuwen Inflight & Travel Products Co., Ltd, Hangzhou | 2018

Out-of-stock
Jonathan W. Chapman
Human Drug Form 483

FDA 483 Shenzhen Techdow Pharmaceutical Co., Ltd., Shenzhen | 2018

Out-of-stock
Jonathan W. Chapman
Human Drug Form 483

FDA 483 Pharmaceutics International, Inc., Cockeysville | 2017

Out-of-stock
Jonathan W. Chapman
Human Drug Form 483

FDA 483 Polymer Solutions Incorporated, Christiansburg | 2017

Out-of-stock
Jonathan W. Chapman
Human Drug Form 483

FDA 483 United Pet Group, Inc. a division of Spectrum Brands, Blacksburg | 2017

Out-of-stock
Jonathan W. Chapman
Animal Drugs & Feed Form 483

FDA 483 Barr Laboratories Inc., Forest | 2017

Out-of-stock
Jonathan W. Chapman
Human Drug Form 483

FDA 483 United Therapeutics Corporation, Silver Spring | 2017

Out-of-stock
Jonathan W. Chapman
Human Drug Form 483

FDA 483 Supernus Pharmaceuticals, Inc., Rockville | 2017

Out-of-stock
Jonathan W. Chapman
Human Drug Form 483

FDA 483 Johns Hopkins University PET Center, Baltimore | 2016

Out-of-stock
Jonathan W. Chapman
Human Drug Form 483

FDA 483 Phyton Biotech GmbH, Ahrensburg | 2016

Out-of-stock
Jonathan W. Chapman
Human Drug Form 483

FDA 483 Bell-More Laboratories Inc, Hampstead | 2016

Out-of-stock
Jonathan W. Chapman
Animal Drugs & Feed Form 483

FDA 483 GlaxoSmithKline dba Human Genome Sciences Inc, Rockville | 2016

Out-of-stock
Jonathan W. Chapman
Human Drug Form 483

FDA 483 Pharmaceutics International, Inc., Hunt Valley | 2016

Out-of-stock
Jonathan W. Chapman
Human Drug Form 483

FDA 483 Stressa Incorporated, Buena Vista | 2016

Out-of-stock
Jonathan W. Chapman
Human Drug Form 483

FDA 483 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Elkton | 2015

Out-of-stock
Jonathan W. Chapman
Human Drug Form 483